Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ZNF148
(ZBP-89, Zfp148) is a multifunctional transcription factor expressed at low levels in most tissues. When overexpressed in gastrointestinal cancer cell lines,
ZNF148
inhibits cellular proliferation and induces apoptosis. We sought to determine whether intestinal
ZNF148
overexpression would abrogate adenoma development in the ApcMin/+ mouse, i.e., whether
ZNF148
is a tumor suppressor. The 13-kb villin promoter was spliced upstream of the
ZNF148
cDNA to generate transgenic villin-
ZNF148
(ZNF148TgVZ) mice. Intestinal mucosal
ZNF148
expression was elevated in four of five
ZNF148
(TgVZ) lineages and correlated with increased
caspase-3
expression and activation. In addition, DNA fragmentation was increased in ZNF148TgVZ mice relative to wild-type littermates. These results suggested that increased intestinal
ZNF148
expression induces apoptosis. ZNF148TgVZ mice were crossed with ApcMin/+ mice to assess the biological significance of intestinal
ZNF148
overexpression. The presence of the ZNF148TgVZ allele in ApcMin/+ mice correlated with reduced gastrointestinal bleeding at 5 weeks, a 50% reduction in adenoma burden at 20-22 weeks, and prolonged survival (median survival of 33.5 days vs. 21.5 days), relative to nontransgenic littermates. These data suggest that enhanced
ZNF148
expression activates intestinal apoptosis and thereby mitigates disease burden in ApcMin/+ mice. They also suggest that
ZNF148
is a therapeutic target to inhibit colon cancer development.
...
PMID:Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia. 1701 48